Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux.
Copper mediated oxidative modification of high density lipoprotein (HDL) diminishes its capacity to promote cholesterol efflux from cells in culture. In the present study, HDL was isolated from eight subjects before and after a 10 day administration of the antioxidant vitamins C and E. After incubation HDL (1.25 mg protein/ml) with 10 microM copper for 0-4 h or with 0-20 microM copper for 4 h, thiobarbituric acid reactive substances (TBARS) production was significantly decreased following vitamin administration suggesting that the vitamins decreased the susceptibility of HDL to oxidation. However, two other assays of lipoprotein oxidation, trinitrobenzene sulfonic acid reactivity and conjugated diene formation, did not show a consistent effect of vitamin administration. To study cholesterol efflux, J774 macrophages were labeled with 3H cholesterol (0.1 microCi/ml, 50 micrograms/ml) and incubated with HDL or oxidized HDL (100 micrograms protein/ml) for 24 h. HDL isolated before vitamins and oxidized in vitro was 39% less effective in mediating efflux compared to unmodified HDL, while HDL isolated after vitamins and oxidized was 22% less effective (before vs. after vitamins, P < 0.015). HDL oxidation determined by measuring TBARS production correlated with decreased cholesterol efflux (r = 0.37, P < 0.050). These data suggest that oxidation of HDL interferes with its role in reverse cholesterol transport and that antioxidant vitamins have a protective effect.
Rifici
V A
VA
Department of Medicine, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick 08903-0019, USA.
Khachadurian
A K
AK
D000328:Adult; D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage*; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D003300:Copper / Q000494:pharmacology*; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005527:Food, Fortified; D006801:Humans; D008075:Lipoproteins, HDL / Q000187:drug effects / Q000378:metabolism*; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D010084:Oxidation-Reduction / Q000187:drug effects; D010537:Peritoneum / Q000166:cytology; D012016:Reference Values; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D014302:Trinitrobenzenesulfonic Acid / Q000378:metabolism; D014810:Vitamin E / Q000008:administration & dosage*
D008075:Lipoproteins, HDL; D017392:Thiobarbituric Acid Reactive Substances; D014810:Vitamin E; D003300:Copper; D014302:Trinitrobenzenesulfonic Acid; D002784:Cholesterol; D001205:Ascorbic Acid